Journal Articles
Disclaimer: The papers below are intended for private viewing by the page owner or those who otherwise have legitimate access to them. No part of it may in any form or by any electronic, mechanical, photocopying, recording, or any other means be reproduced, stored in a retrieval system or be broadcast or transmitted without the prior permission of the respective publishers. If your organization has a valid subscription of the journals, click on the DOI link for the legitimate copy of the papers.
View By Year Published
2020-2021
Coluzzi F, Scerpa MS, Pergolizzi J.
Naldemedine: A new option for OIBD. J Pain Res 2020 13:1209-1222.
DOI: 10.2147/JPR.S243435
Rekatsina M, Paladini A, Piroli A, Zis P, Pergolizzi JV, Varrassi G.
Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: A narrative review. Adv Ther 2020; 37(1):113-39.
DOI 10.1007/s12325-019-01148-5
Varrassi G, Pergolizzi JV, Dowling P, Paladini A.
Ibuprofen safety at the golden anniversary: Are all NSAIDs the same? A narrative review. Adv Ther 2020; 37(1)61-82.
DOI: 10.1007/s12325-019-01144-9,
Pergolizzi JV Jr, Christo PJ, LeQuang JA, Magnusson P.
The use of peripheral mu-opioid receptor antagonists (PAMORA) in the management of opioid-induced constipation: An update on their efficacy and safety. 2020; 14:1009-24.
Ossipov MH, Raffa RB, Pergolizzi JV.
Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache. Drugs Today (Barc) 2020; 56(1):5-19.
DOI 10.1358/dot.2020.56.1.3069863.
Nalamchu S, Pergolizzi J, Kaye R.
Tolperisone for the treatment of acute muscle spasm of the back: Results from the dose-ranging phase 2 STAR Study (NCT03802565). J Pain Res 2020; 13:3059-69.
Pergolizzi JV, Magnusson P, LeQuang JA, Gharibo C, Varrassi G.
The pharmacological management of dental pain. Expert Opin Pharmacotherap 2020 ; 21(5) :591-601.
DOI 10.1080/14656566.2020.1718651.
Pergolizzi JV Jr, Coluzzi F, Colucci RD, Olsson H, LeQuang JA, Al-Saadi J, Magnusson P.
Statins and muscle pain. Expert Rev Clin Pharmacol 2020; 13(3):299-310.
DOI 10.1080/17512433.2020.173445
Pergolizzi JV Jr, LeQuang JA.
Rehabilitation for low back pain: A narrative review for managing pain and improving function in acute and chronic conditions. Pain Ther 2020; 9(1):83-96.
DOI 10.1007/s40122-020-00149-5
Leopoulou M, Mattsson G, LeQuang JA, Pergolizzi JV, Varrassi G, Wallhagen M, Magnusson P.
Naxos disease-a narrative review. Expert Rev Cardiovasc Ther 2020; 18(11):801-8.
DOI 10.1080/14779072.2020.1828064
El-Tallawy SN, Nalamascu R, Pergolizzi JV, Gharibo C.
Pain management during the COVID-19 pandemic. Pain Ther 2020; 9(2):453-66.
DOI 10.1007/s40122-020-00190-4
Pergolizzi JV Jr, Magnusson P, LeQuang JA, Breve F, Paladini A, Rekatsina M, Yeam CT, Imani F, Saltelli G, Taylor R Jr, Wollmuth C, Varrassi G.
The current clinically relevant findings on COVID-19 pandemic. Anesth Pain Med 2020;10(2):e103819.
Pergolizzi JV Jr, Magnusson P, LeQuang JA, Razmi R, Zampogna G, Taylor R Jr.
Statins and neuropathic pain: a narrative review. Pain Ther 2020; 9(1):97-111.
DOI 10.1007/s40122-020-00153-9.
Peppin JF, Pergolizzi JV Jr, Zis P, Paladini A.
The expanding role of the COX inhibitor/opioid receptor agonist combination in the management of pain. Drugs 2020; 80(14)1443-1453.
DOI 10.1007/s40265-020-01369-x.
Pergolizzi JV Jr, Magnusson P, LeQuang JA, Wollmuth C, Taylor R Jr, Breve F.
Exploring the connection between sleep and cluster headache: a narrative review. Pain Ther 2020; 9(2):359-71.
DOI 10.1007/s40122-020-00172-6
Pergolizzi JV, LeQuang JA.
Reappraising the4 use of benzodiazepines in chronic pain patients. Postgrad Med 2020; 132(Sup3):10-12.
DOI 10.1080/00325481.2020.1725352
Pergolizzi JV Jr, Magnusson P, Raffa RB, LeQuang JA, Coluzzi F.
Developments in combined analgesic regimens for improved safety in postoperative pain management. Exp Rev Neurother 2020; 20(9):981-90.
DOI 10.1080/14737175.2020.1806058.
Stolle LB, Nalamascu R, Pergolizzi JV Jr, Varrassi G, Magnusson P, LeQuang J, Breve F.
Fact vs Fallacy: the anti-vaccine discussion reloaded. Adv Ther 2020;37(11)4481-90.
DOI 10.1007/s12325-020-01502-y.
Coluzzi F, Marinagneli F, Pergolizzi J.
Managing chronic pain patients at the time of COVID-19 pandemic. Minerva Anestesiol 2020; 86(8):797-9.
DOI 10.23736/S0375-9393.20.14666-2.
Rekatsina M, Paladini A, Piroli A, Zis P, Pergolizzi JV, Varrassi G.
Pathophsyiologic approach to pain therapy for complex pain entities: A narrative review. Pain Ther 2020; 9(1):7-21.
DOI 10.1007/s40122-019-00147-2.
Pergolizzi JV Jr, Varrassi G, Magnusson P, LeQuang JA, Leopoulou M, Paladini A, Taylor R, Wollmuth C, Breve F.
The concern about ACE/ARB and COVID-19: Time to hold your horses! J Am Pharm Assoc (2003); 2020; 60(6):e88-e90.
DOI 10.1016/j.japh.2020.06.026.
Pergolizzi JV Jr, Raffa RB, Rosenblatt MH.
Opioid withdrawal symptoms, a consequence of chronic opioid use disorder: Current understanding and approaches to management. J Clin Pharm Ther 2020; 45(5):892-903.
Moka E, Paladini A, Rekatsina M, Urits I, Viswanawth O, Kaye AD, Pergolizzi JV, Yeam CT, Varrassi G.
Best practice in cardiac anesthesia during the COVID-19 pandemic: Practical recommdnations. Best Pract Res Clinc Anaethesiol 2020;34(3):569-82l.
Pergolizzi JV Jr, Varrassi G, Magnusson P, LeQuang JA, Paladini A, Taylor R, Wollmuth C, Breve F, Christo P.
COVID-19 and NSAIDs: A narrative review of knowns and unknowns. Pain Ther 2020; 9(2):353-58.
DOI 10.1007/s40122-020-00173-5
Pergolizzi JV Jr.
Exploring the combination of gabapentinoids and opioids for postoperative analgesia. JAMA Netw Open 2020; 3(12)e2032139.
DOI 10.1001/jamanetworkopen.2020.32139.
Rekatsina M, Paladini A, Cifone MG, Lombardi F, Pergolizzi JV, Varrassi G.
Influence of microbiota on NSAID enteropathy: A systematic review of current knowledge and the role of probiotics. Adv Ther 2020; 37(5):1933-45.
Coluzzi F, Pergolizzi JV Jr, Giordan E, Locarini P, Boaro A, Belleci D.
Tapentadol prolonged release for managing moderate to severe chronic neck pain with or without a neuropathic component. Curr Med Res Opin 2020; 365(4):651-9.
DOI 10.1080/03007995.2020.1722083.
Schwenk ES, Pradhan B, Nalamasu R, Stolle L, Wainer IW, Cirullo M, Olson A, Pergolizzi JV, Torjman MC, Viscusi ER.
Ketamine in the past, present, and future: Mechanisms, metabolites and toxicity. Curr Pain Headache Rep. 25(9):57.
DOI 10.1007/s11916-021-00977-w
Pergolizzi JV, Magnusson P, LeQuang JA, Breve F, Taylor R, Wollmuth C, Varrassi G.
Can NSAIDs and acetaminophen effectively replace opioid treatment options for acute pain? Exp Opin Pharmacother 2021; 22(9):1119-26.
DOI 10.1080/14656566.2021.1901885.
Rekatsina M, Paladini A, Drewes AM, Ayob F, Viswanath O, Urits I, Corli O, Pergolizzi J Jr, Varrassi G.
Efficacy and safety of peripherally acting mu-opioid receptor antagonist (PAMORAs) for the management of patients with opioid-induced constipation: a systematic review. Cureus 2021 13(7):316201.
Peppin JF, Pergolizzi JV Jr, Fudin J, Meyer TA, Raffa RB.
History of respiratory stimulants. J Pain Res 2021;14:1043-9.
Pergolizzi JV Jr, Magnssuon PO, LeQuang JAK, Breve F, Varrassi G.
Cocaine and cardiotoxicity : a literature review. Cureus 2021 13(4): e14594.
Pergolizzi J, Breve F, Magnusson P, Nalamasu R, LeQuang JAK, Varrassi G.
Suicide by opioid: exploring the intentionality of the act. Cureus 2021; 13(9):318084.
DOI: 10.7759/cureus.18084
Pergolizzi J, Magnusson P, LeQuang JAK, Breve F.
Illicitly manufactured fentanyl entering the United States. CUREUS 2021 13(8): e17496.
Pergolizzi J Jr, LeQuang JA, Umeda-Raffa S, Fleischer C, Pergolizzi J 3rd, Pergolizzi C, Raffa RB.
The Zika virus: Lurking behind the COVID-19 pandemic? J Clin Pharm Ther 2021; 46(2):267-76.
*Wiley Top Downloaded Article in 2020
Pergolizzi J, LeQuang JAK, Breve F.
The end of the X-waiver: Not a moment too soon! Cureus 2021; 13(5):315123.
Peppin JF, Pergolizzi JV Jr, Dahan A, Raffa RB.
Are opioid receptor antagonists adequate for “opioid” overdose in a changing reality? J Clin Pharm Ther 2021; 46(4)861-6.
Pergolizzi JV Jr, Dahan An Ann LeQuang J, Raffa RB.
Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit. J Clin Pharm Ther 2021; 46(6):1501-4.
Umeda-Raffa S, Pergolizzi JV Jr, Raffa RB.
Bone fractures during the time of coronavirus. J Clin Pharm Ther 2021; 46(2):543-6.
El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JAK, Pergolizzi JV, Christo PJ.
Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther 2021; 10(1):181-209.
DOI 10.1007/s40122-021-00235-2
Pergolizzi JV Jr, Magnusson P, LeQuang JA, Breve F, Mitchell K, Chopra M, Varrassi G.
Transdermal buprenorphine for acute pain in the clinical setting: A narrative review. J Pain Res 2021; 14:871-9.
Pergolizzi JV Jr, LeQuang JA, Raffa RB.
Benzodiazepines: Thinking outside the black box. J Clin Pharm Ther 2021; 46(3):554-9.
Pergolizzi JV Jr, Dahan A, LeQuang JA, Raffa RB.
The conundrum of polysubstance overdose. J Clin Pharm Ther 2021; 46(5):1189-93.
Pergolizzi JV Jr, Magnusson P, Christo PJ, LeQuang JA, Breve F, Mitchell K, Varrassi G.
Opioid therapy in cancer patients and survivors at risk of addiction, misuse, or complex dependency. Front Pain Res (Lausanne) 2021; 2:691720
Stolle L, Nalamasu R, Rodenbeck R, Davidson K, Smarelli C, Rosko S, Wales J, LeQuang JAK, Pergolizzi J.
Ozone: A novel sterilizer for personal protective equipment. Cureus 2021; 13(9):e18228.
Pergolizzi JV Jr, Webster LR, Vortsman E, Ann LeQuang J, Raffa RB.
Wooden chest syndrome: the atypical pharmacology of fentanyl overdose. J Clin Pharm Ther 2021; 46(5):1505-8.
Ayad AE, Salman OH, Ibrahim AMF, Al-Taher WAM, Mishriky AM, Pergolizzi JV, Viswanath O, Urits I, Rekatsina M, Peppin JF, Paladini A, Varrassi G.
Influences of gender on intravenous nalbuphine actions after major abdominal surgery: A multicenter study. Pain Ther 2021; 10(2):1215-33.